Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03055585 |
Date of registration:
|
14/02/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Applying Wolbachia to Eliminate Dengue
AWED |
Scientific title:
|
Applying Wolbachia to Eliminate Dengue (AWED): A Non-blinded Cluster Randomised Controlled Trial to Assess the Efficacy of Wolbachia-infected Mosquito Deployments to Reduce Dengue Incidence in Yogyakarta, Indonesia |
Date of first enrolment:
|
November 8, 2017 |
Target sample size:
|
8173 |
Recruitment status: |
Terminated |
URL:
|
https://clinicaltrials.gov/show/NCT03055585 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Indonesia
| | | | | | | |
Contacts
|
Name:
|
Adi Utarini, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Faculty of Medicine, Universitas Gadjah Mada |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Fever (either self-reported or objectively measured, e.g. (tympanic membrane
temperature =38oC)) of 1-4 days duration, and where onset was prior to the day of
presentation
- Aged between 3-45 years old
- Resided in the study area every night for the 10 days preceding illness onset
Exclusion Criteria:
- Localising features suggestive of a specific diagnosis other than an arboviral
infection e.g. severe diarrhea, otitis, pneumonia
- Prior enrollment in the study within the previous 4 weeks
Age minimum:
3 Years
Age maximum:
45 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Dengue
|
Zika Virus Infection
|
Chikungunya Fever
|
Intervention(s)
|
Biological: Wolbachia-infected Aedes aegypti mosquitoes
|
Other: standard practice dengue control
|
Primary Outcome(s)
|
Relative risk of dengue in Wolbachia-treated versus untreated clusters
[Time Frame: Up to 36 months participant enrolment]
|
Secondary Outcome(s)
|
Relative risk of serotype-specific dengue in Wolbachia-treated versus untreated clusters
[Time Frame: Up to 36 months participant enrolment]
|
Relative risk of Zika in Wolbachia-treated versus untreated clusters
[Time Frame: Up to 36 months participant enrolment]
|
Relative risk of Chikungunya in Wolbachia-treated versus untreated clusters
[Time Frame: Up to 36 months participant enrolment]
|
Secondary ID(s)
|
UGM_KE/FK/105/EC
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|